LadRx Corporation (LADX)

OTCMKTS · Delayed Price · Currency is USD
0.110
+0.080 (266.67%)
Feb 24, 2026, 3:31 PM EST
-95.11%
Market Cap 54.46K
Revenue (ttm) n/a
Net Income (ttm) -2.50M
Shares Out 495.09K
EPS (ttm) -5.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,023
Average Volume 2,053
Open 0.110
Previous Close 0.030
Day's Range 0.110 - 0.110
52-Week Range 0.000 - 2.400
Beta 0.43
RSI 42.50
Earnings Date Mar 11, 2026

About LadRx

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1985
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol LADX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.